Matt Patterson
SelectiveNamed in filings at Stellar VenturesOn the current fund
- Board seats filed
- 9
Named in filings at Stellar VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Addition Therapeutics | Biotech & pharma | December 2025 | None on file |
| LOOPR AI | Not yet classified | July 2025 | None on file |
| Remix Therapeutics | Biotech & pharma | December 2023 | Atlas Venture |
| Brickyard Fund I | Not yet classified | October 2022 | None on file |
| Brickyard Fund I GP | Not yet classified | August 2022 | None on file |
| Brickyard Ender Holdings | Not yet classified | April 2022 | None on file |
| Medico CX | Not yet classified | May 2021 | None on file |
| Brickyard Capital | Not yet classified | May 2021 | None on file |
| Audentes Therapeutics | Biotech & pharma | November 2014 | 270 Healthcare Growth, Asset Management Ventures, Versant Venture Capital |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Matt Patterson on the board, based on 3 filed seats with a verified or cited source.
6 more filed seats not yet classified, left out of the shares above.